Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The First GLP-1 Agonist ETF Is Building a Track Record of Success Investors should know that there is massive potential in the GLP-1 space thanks to the recent proliferation of ETFs dedicated to this investment strategy
Related Research FOXO4-DRI: Senolytic Peptide Mechanism and the p53-FOXO4 Axis FOXO4-DRI is a D-retro-inverso peptide that selectively kills senescent cells by disrupting the protective FOXO4-p53 interaction
Not universally
Novo Nordisk has been particularly hard-hit, with US sales of Wegovy shrank 2% in the final three months of 2025
28-02-2024 Pilar Todo bien
US$ 22.49
US$ 27.59
US$ 22.21
US$ 23.94
